Virtual screening reveals aprepitant to be a potent inhibitor of neutral sphingomyelinase 2: implications in blockade of exosome release in cancer therapy

M Moloudizargari, S Hekmatirad, S Gharaghani… - Journal of Cancer …, 2023 - Springer
Purpose Exosomes are membrane-derived nano-vesicles upregulated in pathological
conditions like cancer. Therefore, inhibiting their release is a potential strategy for the …

Exosome inhibition improves response to first‐line therapy in small cell lung cancer

N Irep, K Inci, PE Tokgun… - Journal of Cellular and …, 2024 - Wiley Online Library
Exosomes are recognized as important mediators of cell‐to‐cell communication, facilitating
carcinogenesis. Although there have been significant advancements in exosome research …

A novel and potent brain penetrant inhibitor of extracellular vesicle release

C Rojas, M Sala, AG Thomas… - British journal of …, 2019 - Wiley Online Library
Background and Purpose Extracellular vesicles (EVs) are constitutively shed from cells and
released by various stimuli. Their protein and RNA cargo are modified by the stimulus, and …

Pharmacological inhibition of exosome machinery: an emerging prospect in cancer therapeutics

S Syeda, K Rawat, A Shrivastava - Current Cancer Drug …, 2022 - ingentaconnect.com
Exosomes are nanocarriers that mediate intercellular communication crucial for normal
physiological functions. However, exponentially emerging reports have correlated their …

Aspirin-loaded nanoexosomes as cancer therapeutics

PHL Tran, T Wang, W Yin, TTD Tran… - International Journal of …, 2019 - Elsevier
The long history of discovery and recently encouraging studies of the anti-cancer effect of
aspirin promise a closer step to widely used aspirin-based medication in cancer therapy. To …

The sphingolipids change in exosomes from cancer patients and association between exosome release and sphingolipids level based on a pseudotargeted …

K Yang, W Fu, M Deng, X Li, M Wu, Y Wang - Analytica Chimica Acta, 2024 - Elsevier
The lipid based ESCRT-independent mechanism, which contributes to MVB formation, is
one of the crucial procedures in exosome biogenesis. n-SMase is a key lipid metabolism …

Sunitinib and SU11652 inhibit acid sphingomyelinase, destabilize lysosomes, and inhibit multidrug resistance

AM Ellegaard, L Groth-Pedersen, V Oorschot… - Molecular cancer …, 2013 - AACR
Defective apoptosis signaling and multidrug resistance are major barriers for successful
cancer treatment. To identify drugs capable of targeting treatment-resistant cancer cells, we …

High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer

A Datta, H Kim, L McGee, AE Johnson, S Talwar… - Scientific reports, 2018 - nature.com
Targeting exosome biogenesis and release may have potential clinical implications for
cancer therapy. Herein, we have optimized a quantitative high throughput screen (qHTS) …

Exosomal neutral sphingomyelinase 1 suppresses hepatocellular carcinoma via decreasing the ratio of sphingomyelin/ceramide

M Lin, W Liao, M Dong, R Zhu, J Xiao, T Sun… - The FEBS …, 2018 - Wiley Online Library
Neutral sphingomyelinase 1 (NSM ase1) mediates caspase‐3 activation and apoptosis.
However, the role of NSM ase1, especially exosome‐borne NSM ase1 in hepatocellular …

Development of a nanoamorphous exosomal delivery system as an effective biological platform for improved encapsulation of hydrophobic drugs

PHL Tran, T Wang, W Yin, TTD Tran, HT Barua… - International journal of …, 2019 - Elsevier
Despite their great potential, the nano-sized extracellular vesicles are yet to become
effective delivery systems for poorly water-soluble drugs. Here, we present a novel platform …